A Post-Market Assessment of the Safety and Performance of the TriClip™ System

Part of paid clinical trials in La Jolla, California.

Sponsor
Abbott Medical Devices
Study ID
NCT07586995
Status
Enrolling By Invitation

Conditions

  • Tricuspid Regurgitation (TR)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Tricuspid Transcatheter Edge-to-Edge Repair (TEER) — DEVICE
    TriClip System

Study Details

The objective of the TREAT TR study is to confirm the safety and performance of the TriClip System for tricuspid TEER in a contemporary, real-world setting, using the commercially available device in accordance with its approved indications for use.

Key Dates

Start date
Jun 30, 2026
Status verified
May 2026
Primary completion
Sep 30, 2028
Completion
Aug 31, 2033

Study Design

Enrollment
1,000 participants (estimated)

Primary Outcome Measure

Rate of Peri-Procedural Adverse Events [ Time Frame: Through 30 days post-procedure ]

Locations (2)

FacilityCityStateZIPSite coordinators
Scripps HealthLa JollaCalifornia92037-
Northwestern Memorial HospitalChicagoIllinois60611-

Find similar trials in La Jolla, CA

By research site
Scripps Health· La Jolla, CANorthwestern Memorial Hospital· Chicago, IL

Related Studies